Publikationen von Tiago F. Outeiro
Alle Typen
Zeitschriftenartikel (101)
41.
Zeitschriftenartikel
7, 65 (2021)
Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease. NPJ Parkinsons Disease 42.
Zeitschriftenartikel
87, S. 70 - 85 (2021)
JM-20 treatment prevents neuronal damage and memory impairment induced by aluminum chloride in rats. NeuroToxicology 43.
Zeitschriftenartikel
Molecular characterization of an aggregation-prone variant of alpha-synuclein used to model synucleinopathies. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics (2020)
44.
Zeitschriftenartikel
404, S. 58 - 71 (2020)
Tapentadol Prevent Motor Impairments in a Mouse Model of Dyskinesia. Neuroscience 45.
Zeitschriftenartikel
116 (51), S. 25991 - 2600 (2019)
Characterization of the activity, aggregation, and toxicity of heterodimers of WT and ALS-associated mutant Sod1. Proceedings of the National Academy of Sciences of the United States of America 46.
Zeitschriftenartikel
28, S. 65 - 77 (2019)
Cytosolic trapping of a mitochondrial heat shock protein is an early pathological event in synucleinopathies. Cell Reports 47.
Zeitschriftenartikel
47, S. 909 - 918 (2019)
Investigating targets for neuropharmacological intervention by molecular dynamics simulations. Biochemical Society Transactions 48.
Zeitschriftenartikel
8, 18 (2019)
Dihydromyricetin and salvianolic acid B inhibit alpha-synuclein aggregation and enhance chaperone-mediated autophagy. Translational neurodegeneration 49.
Zeitschriftenartikel
47 (3), S. 827 - 838 (2019)
LRRK2, alpha-synuclein, and tau: partners in crime or unfortunate bystanders? Biochemical Society Transactions 50.
Zeitschriftenartikel
85 (5), S. 691 - 703 (2019)
Seeding variability of different alpha synuclein strains in synucleinopathies. Annals of Neurology 51.
Zeitschriftenartikel
12, 107 (2019)
Spreading of α-synuclein and tau: a systematic comparison of the mechanisms involved. Frontiers in Molecular Neuroscience 52.
Zeitschriftenartikel
22, 101135 (2019)
Biasing the native α-synuclein conformational ensemble towards compact states abolishes aggregation and neurotoxicity. Redox Biology 53.
Zeitschriftenartikel
47, S. 197 - 207 (2019)
The role of LRRK2 in cell signalling. Biochemical Society Transactions 54.
Zeitschriftenartikel
33 (2), S. 2116 - 2131 (2019)
Monitoring α-synuclein multimerization in vivo. The FASEB Journal 55.
Zeitschriftenartikel
14, 5 (2019)
Dementia with Lewy bodies: an update and outlook. Molecular neurodegeneration 56.
Zeitschriftenartikel
27 (1), S. 79 - 91 (2019)
Synthesis and evaluation of esterified Hsp70 agonists in cellular models of protein aggregation and folding. Bioorganic & Medicinal Chemistry 57.
Zeitschriftenartikel
28 (1), S. 31 - 50 (2019)
Nuclear localization and phosphorylation modulate pathological effects of alpha-synuclein. Human Molecular Genetics 58.
Zeitschriftenartikel
18 (8), foy108 (2018)
Identification of novel protein phosphatases as modifiers of alpha-synuclein aggregation in yeast. FEMS Yeast Research 59.
Zeitschriftenartikel
33 (11), S. 1675 - 1684 (2018)
Sensing α-Synuclein from the outside via the prion problem: implications for neurodegeneration. Movement Disorders 60.
Zeitschriftenartikel
55, S. 8754 - 8763 (2018)
Diabetes mellitus as a risk factor for Parkinson's disease: a molecular point of view. Molecular Neurobiology